On-Demand Downstream Manufacturing Webinars
-
Overcoming mAbs Development Challenges
3/29/2023
Therapeutic monoclonal antibodies (mAbs) show great promise for treating a variety of diseases. Watch this expert discussion on challenges and obstacles in mAbs development, optimizing processes, and selecting the right partner.
-
Development Of Protein A Continuous Chromatography
3/22/2023
This presentation focuses on the conversion of a batch ProA step using Amsphere A3 resin to a 4-column continuous process on a BioSMB system.
-
Break Free From The Protein A Low-Productivity Paradigm
3/22/2023
Protein A resins, with low flow rates and mass transport, lead to low productivity. Discover a solution that removes the bottleneck, offering a disposable alternative for mAb capture.
-
Overcome The Hidden Complexities Of mRNA Process Development
3/22/2023
Explore the challenges behind the perceived simplicity of mRNA process development, as well as characterization strategies and models for predicting process outcomes at early stages.
-
How mRNA Manufacturers Disrupt The Industry
3/21/2023
Learn how biopharmaceutical companies can apply proven strategies to overcome hidden complexities in mRNA production, and discover solutions that can help you rapidly design and build a SU facility.
-
Bioburden And EU GMP Annex 1: Risk Assessment, Reduction, And Testing
3/10/2023
Experts on regulation, filtration, sampling, and quality control discuss risk assessment and filtration-based strategies to reduce bioburden.
-
Reimagining Data Management For Faster, Smarter BioProcess Development
1/24/2023
Discover solutions to create a digital data backbone and best practices for laying the foundation for advanced analytics to make process understanding easier and more efficient.
-
Advances In mAb Purification
1/18/2023
Learn from industry experts about the purification of monoclonal antibodies, recent innovations and trends, and ways to improve your biopharmaceutical processing.
-
A Rapid, Innovative Approach To Release Testing
12/12/2022
Innovative molecular methods will allow mAbs manufacturers to deliver critical therapeutic agents to patients faster. Learn about a powerful tool that accelerates bulk harvest testing.
-
Accelerate Stability Studies To Optimize An Antigen For HIV-Vaccine Research
11/21/2022
Walk through the process of selecting an optimal buffer for a vaccine antigen and some steps you can follow to help make your own decision.